Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Chaoyang
Clinical trial register · China

Clinical Trials in Chaoyang, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19257 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:17 UTC
19257
Studies in scope
all four open statuses
11829
Recruiting now
open to new participants
2031
Lead sponsors
across recruiting studies
Top sites
Beijing 5598 Shanghai 3888 Guangzhou 3358 Hangzhou 1831 Wuhan 1343

Trials with a site in Chaoyang

11 of 19257 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
First Hospital of China Medical University
Phase 3
864
Fuzhou, Anshan, Benxi, Chaoyang, Dalian, Dandong, Fushun, Fuxin
2026-03-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
190
Bengbu, Chaoyang, Fuzhou, Guandong, Harbin, Wuhan, Changsha, Nanchang
2026-01-26
Active, closed
Ferring Pharmaceuticals
Observational
2,549
Hefei, Ma’anshan, Beijing, Chaoyang, Xicheng, Guangzhou, Shantou, Nanning
2025-08-05
Not yet open
29-Gene Liver Cancer Subtype and Immunotherapy Effectiveness
NCT07100236Primary Hepatocellular Carcinoma
Junjie Xu
Observational
350
Hefei, Chaoyang, Fuzhou, Guangzhou, Zhengzhou, Shanghai, Hangzhou, Wenzhou
2025-08-01
Active, closed
Boehringer Ingelheim
Phase 3
8,371
Anshan, Beijing, Changzhi, Chaoyang, Chengdu, Chifeng, Chongqing, Foshan
2024-08-30
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Chaoyang, Chengdu, Hangzhou, Jinhua, Nanjing, Wuhan
2022-09-19
Recruiting
Betta Pharmaceuticals Co., Ltd.
Phase 1
110
Chaoyang, Cangzhou, Tianjin
2022-08-29
Active, closed
ArriVent BioPharma, Inc.
Phase 1
160
Hefei, Beijing, Chaoyang, Chongqing, Harbin, Zhengzhou, Wuhan, Xuzhou
2022-06-30
Recruiting
Boston Scientific Corporation
Observational
5,000
Chaoyang, Xicheng, Chongqing, Guangzhou, Qingdao, Huangpu, Yangpu, Taiyuan
2021-03-29
Recruiting
The Chinese Familial Alzheimer's Network
NCT03657732Alzheimer Disease, Familial Alzheimer Disease (FAD)
Capital Medical University
Observational
40,000
Hefei, Changping, Chaoyang, Fengtai, Haidian, Xicheng, Yuzhong, Fujian
2005-01-10
Recruiting
China Cognition and Aging Study
NCT03653156Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD), Vascular Dementia (VaD)
Capital Medical University
Observational
100,000
Hefei, Changping, Chaoyang, Fengtai, Haidian, Xicheng, Yuzhong, Fujian
2000-01-01
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-china/city/chaoyang

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,257 studies in total at the last sync on 13 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies with a site in Chaoyang.

How many clinical trials are recruiting in Chaoyang?

5 of the 11 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:17 UTC sync. A further 2 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chaoyang), 11 studies
PhaseStudiesRecruitingShare
Observational5345.5%
Phase 12118.2%
Phase 32018.2%
Not applicable119.1%
Phase 2109.1%

Most active sponsors

Lead sponsors with the most studies (Chaoyang)
Lead sponsorStudiesRecruiting
Capital Medical University22
ArriVent BioPharma, Inc.10
Betta Pharmaceuticals Co., Ltd.11
Boehringer Ingelheim10
Boston Scientific Corporation11
Ferring Pharmaceuticals10
First Hospital of China Medical University10
Janssen Research & Development, LLC10
Junjie Xu10
Second Affiliated Hospital, Zhejiang University, School of Medicine11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.